(Q44763125)

6 December 2017

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial (English)

1 reference

Spontaneous bacterial peritonitis

6 December 2017

1 reference

1 reference

1

1 reference

6 December 2017

Rimola A

2

1 reference

6 December 2017

Planas R

3

1 reference

6 December 2017

Vargas V

4

1 reference

6 December 2017

Marco F

5

1 reference

6 December 2017

Almela M

6

1 reference

6 December 2017

Forné M

7

1 reference

6 December 2017

Miranda ML

8

1 reference

6 December 2017

Llach J

9

1 reference

6 December 2017

Salmerón JM

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

6 December 2017

1 reference

6 December 2017

12

1 reference

6 December 2017

4 Pt 1

1 reference

6 December 2017

716-724

1 reference

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Norfloxacin: a new targeted fluoroquinolone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

In vitro antibacterial activity of norfloxacin (MK-0366).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

Spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Spontaneous bacterial peritonitis: an explosion of information

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Colonization resistance of the digestive tract: clinical consequences and implications.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Norfloxacin for prevention of bacterial infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Impact of imipenem/cilastatin therapy on normal fecal flora.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis: variations on a theme

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Spontaneous Bacterial Peritonitis in Cirrhosis: Endemic or Epidemic?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120416

7 January 2021

Identifiers

DOI

10.1002/HEP.1840120416

1 reference

6 December 2017

1 reference